Loading clinical trials...
Loading clinical trials...
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III, a Prospective Phase II Treatment Trial
Conditions
Interventions
Radiotherapy combined with cisplatin
Cisplatin
Locations
27
United States
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California, United States
Mount Sinai Medical Center
Miami Beach, Florida, United States
Baystate Medical Center
Springfield, Massachusetts, United States
Spectrum Health at Butterworth Campus
Grand Rapids, Michigan, United States
Munson Medical Center
Traverse City, Michigan, United States
Nebraska Methodist Hospital
Omaha, Nebraska, United States
Start Date
January 1, 2021
Primary Completion Date
January 1, 2028
Completion Date
January 1, 2029
Last Updated
August 1, 2023
NCT07085442
NCT05639972
NCT06639191
NCT06447064
NCT05763641
NCT07040657
Lead Sponsor
University Medical Center Groningen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions